Stifel Financial Corp Gilead Sciences, Inc. Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

A detailed history of Stifel Financial Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 1,824,654 shares of GILD stock, worth $153 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

1,824,654

Previous 1,820,845 0.21%

Holding current value

$153 Million

Previous $133 Million 6.14%

% of portfolio

0.14%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $240,538 - $277,599	3,809 Added 0.21%	1,824,654 $125 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $12.4 Million - $15.1 Million	172,978 Added 10.5%	1,820,845 $133 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $1.54 Million - $1.74 Million	-20,990 Reduced 1.26%	1,647,867 $133 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $2.24 Million - $2.44 Million	30,278 Added 1.85%	1,668,857 $125 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $3.13 Million - $3.57 Million	-41,209 Reduced 2.45%	1,638,579 $126 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $15 Million - $17.1 Million	-193,768 Reduced 10.34%	1,679,788 $139 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $3.75 Million - $5.38 Million	-60,180 Reduced 3.11%	1,873,556 $161 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $2.29 Million - $2.61 Million	38,431 Added 2.03%	1,933,736 $119 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $4.57 Million - $5.15 Million	79,254 Added 4.36%	1,895,305 $117 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.85 Million - $2.32 Million	32,015 Added 1.79%	1,816,051 $108 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $3.7 Million - $4.2 Million	56,988 Added 3.3%	1,784,036 $130 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $230,010 - $248,155	3,398 Added 0.2%	1,727,048 $121 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $1.19 Million - $1.3 Million	-18,740 Reduced 1.08%	1,723,650 $119 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $2.17 Million - $2.48 Million	36,226 Added 2.12%	1,742,390 $113 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $12.3 Million - $14 Million	-217,414 Reduced 11.3%	1,706,164 $99.4 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $666,705 - $838,266	10,736 Added 0.56%	1,923,578 $122 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $178,462 - $207,228	-2,467 Reduced 0.13%	1,912,842 $147 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $41.4 Million - $53 Million	660,510 Added 52.64%	1,915,309 $143 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $1.38 Million - $1.52 Million	-22,421 Reduced 1.76%	1,254,799 $81.4 Million
Q3 2019 Nov 19, 2019	SELL	$62.51 - $69.0 $21,378 - $23,598	-342 Reduced 0.03%	1,277,220 $80.9 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $5.56 Million - $6.14 Million	88,958 Added 7.48%	1,277,562 $80.9 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $1.11 Million - $1.25 Million	-17,965 Reduced 1.49%	1,188,604 $80.3 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $3.65 Million - $4.09 Million	-58,368 Reduced 4.61%	1,206,569 $78.5 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $109,456 - $142,832	1,808 Added 0.14%	1,264,937 $79.2 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $12.6 Million - $13.9 Million	176,659 Added 16.26%	1,263,129 $97.5 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $2.79 Million - $3.26 Million	43,025 Added 4.12%	1,086,470 $76.9 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $115,597 - $140,925	-1,587 Reduced 0.15%	1,043,445 $78.8 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $5.31 Million - $6.24 Million	74,687 Added 7.7%	1,045,032 $74.9 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $70 Million - $82.9 Million	970,345	970,345 $0

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Gilead Sciences, Inc. Transaction History